The 1G/1G+1G/2G Genotypes of MMP1 rs1799750 Are Associated with Higher Levels of MMP-1 and Are Both Associated with Lipodystrophy in People Living with HIV on Antiretroviral Therapy
Authors:
- Andreia Soares da SilvaASAndreia Soares da Silva
- Maria Do Socorro de Mendonça CavalcantiMCMaria Do Socorro de Mendonça Cavalcanti
- Taciana Furtado de Mendonça BelmontTBTaciana Furtado de Mendonça Belmont
- Ricardo Arraes de Alencar XimenesRXRicardo Arraes de Alencar Ximenes
- Débora Nascimento da NóbregaDNDébora Nascimento da Nóbrega
- Roberta dos Santos SouzaRSRoberta dos Santos Souza
- Isabela Cristina Cordeiro FariasIFIsabela Cristina Cordeiro Farias
- Kleyton Palmeira Do ÓKÓKleyton Palmeira Do Ó
- Luydson Richardson Silva VasconcelosLVLuydson Richardson Silva Vasconcelos
- George Tadeu Nunes DinizGDGeorge Tadeu Nunes Diniz
- Demócrito de Barros Miranda-FilhoDMDemócrito de Barros Miranda-Filho
- 29 April 2021
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 37 (5) , 399-406
Abstract
In HIV-infected patients, antiretroviral therapy (ART) is associated to adipose tissue redistribution known as lipodystrophy (LD). This study aimed at verifying the association between the polymorphism of the MMP1 gene (rs1799750) (1G/2G) and the serum levels of matrix metalloproteinase 1 (MMP-1) with LD and its subtypes in people living with HIV on ART. This is a cross-secional study. LD was self-reported. The determination of the MMP1 rs1799750 gene polymorphism was performed by real-time PCR, and the serum concentrations of MMP-1 were quantified by the enzyme-linked immunosorbent assay (ELISA) method. Of 404 participants, 204 (51%) were diagnosed with LD, of whom 89 (43%) had mixed lipodystrophy (ML), 72 (35%) had lipohypertrophy (LH), and 43 (22%) had lipoatrophy (LA). There was an association between the genotypes 1G/1G+1G/2G and higher serum levels of MMP-1 ( p = .025). There was no association of MMP1 (1G/2G) with LD. Other factors associated with LD were current CD4 ≤ 350 [odds ratio (OR) = 4.85, confidence interval (CI) = 1.78–47.99, p = .0033] and serum MMP-1 levels >6.81 (OR = 2.67, CI = 1.21–6.08, p = .0165). Factors associated with ML: current CD4 ≤ 350 (OR = 5.59, CI = 1.69–20.39, p = .006); with LH: number of antiretroviral regimens used: 2 (OR = 2.06, CI = 1.01–4.20, p = .0460) and 3+ (OR = 2.09, CI = 1.00–4.35, p = .0477), and current CD4 ≤ 350 (OR = 2.08, CI = 1.00–4.24, p = .0461); and with LA: current viral load >40 (OR = 2.52, CI = 1.03–5.91, p = .0372) and current use of zidovudine (OR = 2.97, CI = 1.32–6.54, p = .0074). Higher levels of MMP-1 were associated with genotypes 1G/2G+1G/1G and with LD. Other individual risk factors were independently associated with LD, and its subtypes, suggesting that the pathogenesis itself is differently manifested for each type of LD.Keywords
This publication has 41 references indexed in Scilit:
- HIV-Associated Lipodystrophy: Impact of Antiretroviral TherapyDrugs, 2013
- Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesityBMC Medical Genetics, 2013
- Genetic Markers Associated to Dyslipidemia in HIV‐Infected Individuals on HAARTThe Scientific World Journal, 2013
- MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphismsBMC Genomics, 2011
- The MMP1 (−16071G/2G) single nucleotide polymorphism associates with the HAART-related lipodystrophic syndromeAIDS, 2010
- Risk Factors in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients Undergoing Antiretroviral Therapy in the State of Pernambuco, Brazil: A Case–Control StudyMetabolic Syndrome and Related Disorders, 2010
- Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virusClinical and Experimental Dermatology, 2010
- YKL-40 secreted from adipose tissue inhibits degradation of type I collagenBiochemical and Biophysical Research Communications, 2009
- Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugsAIDS, 2006
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004